Bharat Forge infuses Rs 290.51 crore into Kalyani Strategic Systems
Bharat Forge Limited completed a further investment of Rs 290.51 crore in its wholly owned defence subsidiary Kalyani Strategic Systems Limited (KSSL) on 18 November 2026, subscribing to a rights issue of 29,05,08,000 equity shares at Rs 10 each, which is face value. The money comes from the proceeds of the company's qualified institutional placement and internal accruals. Bharat Forge shares rose as much as 2.7% to Rs 1,730.40 on the NSE on 19 November 2026.
What exactly did Bharat Forge disclose?
According to the regulatory filing, Bharat Forge invested Rs 2,90,50,80,000 and received 29,05,08,000 fully paid-up equity shares of KSSL. The board had authorised a further investment of up to Rs 290.51 crore at its meeting on 5 November 2026, and the allotment completed that approval.
A rights issue at par means the new shares were issued at face value of Rs 10 with no premium. Because KSSL is wholly owned, the entire issue went to Bharat Forge and the shareholding structure does not change.
The transaction in numbers
| Amount invested | Rs 290.51 crore |
| Shares allotted | 29,05,08,000 equity shares |
| Issue price | Rs 10 per share (at par) |
| Route | Rights issue by KSSL |
| Board approval | 5 November 2026 |
| Completion date | 18 November 2026 |
| Funding source | QIP proceeds and internal accruals |
This is the second tranche in under three weeks
Bharat Forge had completed an earlier rights issue investment of Rs 240 crore in KSSL on 30 October 2026, covering 24 crore shares.
GoPocket calculation: the two tranches add up to Rs 530.51 crore of fresh equity into KSSL between 30 October and 18 November 2026, and the second tranche is about 21% larger than the first. Method: 240 plus 290.51 for the total; (290.51 divided by 240) minus 1 for the increase. The pace of funding indicates how quickly capital is being committed to the defence arm. It does not establish the size of KSSL's order book, revenue or profitability, none of which are disclosed in these filings.
Why capital infusions into a subsidiary matter
Equity put into a wholly owned subsidiary does not leave the group. It moves from the parent's cash to the subsidiary's balance sheet, where it can fund capacity, working capital or new programmes. On consolidated accounts the transaction largely nets off; on the standalone parent accounts it reduces cash and increases the investment carried against KSSL.
For investors, the useful question is not the accounting treatment but what the capital is being used for and over what period it converts into revenue. Defence programmes typically run on multi-year qualification and delivery cycles.
Separately, exchange filings on 19 November 2026 noted that Bharat Forge flagged off rifle consignments, which relates to the group's small-arms business.
Risks and limitations
Capital infusion is an input, not an outcome. KSSL supplies components and subsystems into defence programmes, where order timing depends on government procurement cycles, trials and budget allocation, all of which can slip. Using QIP proceeds for subsidiary equity also means that cash is no longer available for other uses. None of the filings quantify expected returns from the investment, and no revenue or margin guidance for KSSL has been provided.
What to monitor next
- Any further rights-issue tranches into KSSL
- Disclosed defence order wins at group or subsidiary level
- The defence segment's share of consolidated revenue in quarterly results
- Remaining unutilised QIP proceeds, which listed companies report periodically
- Execution updates on small-arms and artillery programmes
Track Bharat Forge share price and its filings on GoPocket.
Sources
- NSE corporate announcements - Bharat Forge filing on the KSSL allotment
- Free Press Journal - transaction value, share allotment and board approval date
- EquityPandit - completion on 18 November 2026 and allotment detail
This article is for informational and educational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Views attributed to third parties are those of the respective analysts and not of GoPocket. Investments in securities markets are subject to market risks; read all related documents carefully before investing.
GoPocket Invest Tech Private Limited - SEBI Reg. No. INZ000049235 | ARN: 136818